Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy

Accept / Decline

Areas of interest

  • Reproductive medicine and women's health
    Reproductive medicine and women's health

  • At Ferring, we are committed to helping people become parents, and to keeping mothers and babies healthy from conception to birth.

    A scientific leader in fertility, obstetrics and gynaecology, our reproductive health products complement natural processes to help couples conceive and ensure healthy pregnancies and births.

    In order to expand our portfolio and address tomorrow’s patient and physician needs, we are looking for:

    • Novel fertility treatments, technologies and support services to assist physicians and patients in the journey towards conception
    • High quality treatments to support every stage of the reproductive cycle
    • Innovative treatments and solutions to meet unmet needs of women and babies in pregnancy and childbirth
    • Novel treatments and solutions to help women suffering from poorly managed gynaecological conditions, such as endometriosis
  • Gastroenterology and Hepatology
    Gastroenterology and Hepatology

  • We have a strong heritage of clinical research and educational support in the area of inflammatory bowel diseases (IBD) and bowel cleansing.


    We are looking for:

    • Products for the treatment and long-term management of IBD to complement our Pentasa ® (mesalazine) franchise.
    • Novel therapeutic approaches to treat immune-mediated and metabolic gastrointestinal diseases, including IBD
    • Novel therapeutic approaches to treat immune-mediated and metabolic hepatic diseases, including nonalcoholic steatohepatitis (NASH).
    • Treatments for complications of end-stage liver disease such as ascites, acute kidney injury and hepatic encephalopathy
  • Urology

  • We are a leader in providing solutions for nocturia, the need to wake up and urinate more than once at night, and bedwetting in children, also known as enuresis. We also aim to be a specialist global leader in the treatment of additional urologic diseases such as castration sensitive prostate cancer and non muscle invasive bladder cancer (NMIBC).


    We are looking for:

    • Medicines to treat urological disorders such as enuresis, nocturia, BPH and inflammatory conditions of the urinary tract.
    • Treatments and technologies targeting urological cancers such as bladder and prostate.
      Other opportunities targeting the urologist segment.
  • Orthopaedics

  • Ferring is a leader in the treatment of knee osteoarthritis in the US, and we are looking to expand this leadership globally. We aim to facilitate evidence-based medical decisions and to develop treatments for musculoskeletal diseases.

    We are looking for:

    • Orthobiologics and regenerative therapies for the knee, hip, shoulder, spine and ankle.
  • Endocrinology

  • Ferring was the first company to synthesise pituitary hormones on an industrial scale in the early 1950s. Today, our endocrine products treat numerous conditions, including diabetes insipidus, growth hormone disorders and modulation of the GnRH axis.

    We are looking for:

    • Endocrine treatments outside of metabolic syndrome and diabetes.



TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10


Global Locator